Biocryst Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 22.65 M | $215.64 M | 7.16% | 10.74% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 15.83 M | $150.67 M | 0.00% | 7.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 15.04 M | $143.16 M | 4.86% | 7.13% |
| STATE STREET CORP | 05/15/2026 | 12.21 M | $116.22 M | 10.25% | 5.79% |
| 05/08/2026 | 11.24 M | $107.05 M | 100.00% | 5.33% | |
| 05/15/2026 | 11.14 M | $106.01 M | 100.00% | 5.28% | |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 11.02 M | $104.92 M | 100.00% | 5.22% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 8.91 M | $84.85 M | 20.31% | 4.22% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 7.43 M | $70.77 M | 135.07% | 3.52% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 7.03 M | $66.88 M | 212.22% | 3.33% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 6.39 M | $60.86 M | 41.58% | 3.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 5.78 M | $55.06 M | 14.42% | 2.74% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 5.68 M | $54.08 M | -39.35% | 2.69% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 5.09 M | $48.47 M | 231.59% | 2.41% |
| ABRDN PLC | 04/29/2026 | 5.04 M | $47.99 M | 451.74% | 2.39% |
| UBS GROUP AG | 05/05/2026 | 4.94 M | $47.07 M | -6.08% | 2.34% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 4.01 M | $38.17 M | 100.00% | 1.90% |
| 05/14/2026 | 3.85 M | $36.62 M | 0.00% | 1.82% | |
| NUVEEN, LLC | 04/30/2026 | 3.82 M | $36.36 M | 5.73% | 1.81% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 3.24 M | $30.85 M | 2.52% | 1.54% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 3.04 M | $28.94 M | 1.57% | 1.44% |
| RFG ADVISORY, LLC | 04/20/2026 | 2.87 M | $27.33 M | 100.00% | 1.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 2.82 M | $26.80 M | 319.14% | 1.33% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 2.73 M | $26.02 M | 10.77% | 1.30% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 2.69 M | $25.61 M | 118.96% | 1.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 2.35 M | $22.38 M | 17.23% | 1.11% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.35 M | $22.35 M | -26.93% | 1.11% |
| CANDRIAM S.C.A. | 04/30/2026 | 2.29 M | $21.77 M | 100.00% | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/15/2026 | 2.23 M | $21.23 M | 17.12% | 1.06% |
| NORTHERN TRUST CORP | 05/14/2026 | 2.10 M | $20.04 M | 13.35% | 1.00% |
| MORGAN STANLEY | 05/15/2026 | 2.02 M | $19.26 M | 15.89% | 0.96% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.99 M | $18.92 M | 46.52% | 0.94% |
| STIFEL FINANCIAL CORP | 05/12/2026 | 1.83 M | $17.38 M | 0.04% | 0.87% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 1.71 M | $16.26 M | 89.78% | 0.81% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.66 M | $15.84 M | 100.00% | 0.79% |
| PACER ADVISORS, INC. | 06/18/2026 | 1.56 M | $14.88 M | 100.00% | 0.74% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.54 M | $14.57 M | 82.84% | 0.73% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 1.43 M | $13.57 M | -18.18% | 0.68% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 1.41 M | $13.43 M | 568.82% | 0.67% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 1.34 M | $12.73 M | 845.71% | 0.63% |
| INVESCO LTD. | 05/12/2026 | 1.31 M | $12.46 M | -3.40% | 0.62% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 1.30 M | $12.40 M | -48.78% | 0.62% |
| MAN GROUP PLC | 05/15/2026 | 1.29 M | $12.31 M | 217.10% | 0.61% |
| 04/10/2026 | 1.25 M | $11.93 M | 800.00% | 0.59% | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 1.23 M | $11.68 M | 100.00% | 0.58% |
| JUPITER ASSET MANAGEMENT LTD | 05/12/2026 | 1.20 M | $11.39 M | -0.10% | 0.57% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.02 M | $9.70 M | -21.57% | 0.48% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 1.00 M | $9.56 M | -2.63% | 0.48% |
| 05/15/2026 | 1.00 M | $9.52 M | -53.49% | 0.47% | |
| ROSALIND ADVISORS, INC. | 05/14/2026 | 923.06 K | $8.79 M | 100.00% | 0.44% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biocryst Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 401 institutional investors and hedge funds held shares of Biocryst Pharmaceuticals Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 22.65 M
RA CAPITAL MANAGEMENT, L.P.: 15.83 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 15.04 M
STATE STREET CORP: 12.21 M
TCG Crossover Management, LLC: 11.02 M
JANUS HENDERSON GROUP PLC: 8.91 M
118.05% of Biocryst Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 292.58 M shares in the last 24 months. This purchase volume represents approximately $2.52 B in transactions.